title: Advances in prevention and management of central line-associated bloodstream infections in patients with cancer.
abstract: Central lines, which are essential for treating cancer, are associated with at least 400,000 episodes of bloodstream infection in patients with cancer every year in the United States. Effective novel interventions for preventing and managing these infections include antimicrobial-coated catheters and antimicrobial lock solutions.
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Issam
authors.initials: I
authors.lastname: Raad
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Chaftari
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000150:complications*
chemical_list: D000900:Anti-Bacterial Agents
keywords: cancer patients; catheter-related infections; central line–associated bloodstream infections; central venous catheters; prevention and management